Ivabradine for treatment of stable angina pectoris

被引：0
作者：
Ranil de Silva
Kim M. Fox
机构：
[1] Royal Brompton and Harefield NHS Trust,Department of Cardiology
[2] National Heart and Lung Institute,undefined
[3] Imperial College London,undefined
来源：
Nature Reviews Cardiology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The ASSOCIATE study investigators have reported that the If current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic stable angina being treated with atenolol. Ivabradine should be considered in the medical management of symptom-limited patients with angina, when heart rate is suboptimally controlled.
引用
收藏
页码：329 / 330
页数：1
相关论文
共 50 条
  • [21] The Role of Ivabradine in the Management of Angina Pectoris
    Giavarini, Alessandra
    de Silva, Ranil
    CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (04) : 407 - 417
  • [22] The Role of Ivabradine in the Management of Angina Pectoris
    Alessandra Giavarini
    Ranil de Silva
    Cardiovascular Drugs and Therapy, 2016, 30 : 407 - 417
  • [23] Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study
    Zarifis, John
    Grammatikou, Violetta
    Kallistratos, Manolis
    Katsivas, Apostolos
    CLINICAL CARDIOLOGY, 2015, 38 (12) : 725 - 732
  • [24] Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
    Kashtalap, Vasiliy V.
    Barbarash, Olga L.
    Sedykh, Darya Yu
    Krivoshapova, Kristina E.
    Tsygankova, Darya P.
    Tsygankova, Oksana, V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (05) : 663 - 669
  • [25] Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
    Chaturvedi, Aditi
    Singh, Yogendra
    Chaturvedi, Harish
    Thawani, Vijay
    Singla, Sakshi
    Parihar, Deepak
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) : 33 - 38
  • [26] Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice
    Koester, Ralf
    Kaehler, Jan
    Ebelt, Henning
    Soeffker, Gerold
    Werdan, Karl
    Meinertz, Thomas
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (10) : 665 - 672
  • [27] COMPARING THE COST-EFFECTIVENESS OF IVABRADINE WITH ISOSORBIDE MONONITRATE, AMLODIPINE, DILTIAZEM AND VERAPAMIL, IN THE TREATMENT OF STABLE ANGINA PECTORIS
    Oto, A.
    Ergene, O.
    Erol, M. K.
    Kucukoglu, S.
    Ozdemir, O.
    Tan, M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S62 - S63
  • [28] Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice
    Ralf Koester
    Jan Kaehler
    Henning Ebelt
    Gerold Soeffker
    Karl Werdan
    Thomas Meinertz
    Clinical Research in Cardiology, 2010, 99 : 665 - 672
  • [29] Stable Angina Pectoris: Current Medical Treatment
    Siama, Katerina
    Tousoulis, Dimitris
    Papageorgiou, Nikolaos
    Siasos, Gerasimos
    Tsiamis, Eleftherios
    Bakogiannis, Constantinos
    Briasoulis, Alexandros
    Androulakis, Emmanuel
    Tentolouris, Kostas
    Stefanadis, Christodoulos
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (09) : 1569 - 1580
  • [30] Rate Control with Ivabradine Angina Pectoris and Beyond
    Parakh, Neeraj
    Bhargava, Balram
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (01) : 1 - 12
12345